Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 376

1.

Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series.

Joubert B, García-Serra A, Planagumà J, Martínez-Hernandez E, Kraft A, Palm F, Iizuka T, Honnorat J, Leypoldt F, Graus F, Dalmau J.

Neurol Neuroimmunol Neuroinflamm. 2020 Jan 16;7(3). pii: e668. doi: 10.1212/NXI.0000000000000668. Print 2020 May.

2.

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.

Manson G, Maria ATJ, Poizeau F, Danlos FX, Kostine M, Brosseau S, Aspeslagh S, Du Rusquec P, Roger M, Pallix-Guyot M, Ruivard M, Dousset L, Grignou L, Psimaras D, Pluvy J, Quéré G, Grados F, Duval F, Bourdain F, Maigne G, Perrin J, Godbert B, Taifas BI, Forestier A, Voisin AL, Martin-Romano P, Baldini C, Marabelle A, Massard C, Honnorat J, Lambotte O, Michot JM.

J Immunother Cancer. 2019 Dec 3;7(1):337. doi: 10.1186/s40425-019-0821-8.

3.

Successful Management of Anti-mGluR1 Encephalitis with Immunosuppressive Treatment: Dengue Virus as a Trigger?

Chaumont H, Petit A, Mameri T, Schollhammer R, Honnorat J, Lannuzel A.

Mov Disord Clin Pract. 2019 Oct 23;6(8):727-728. doi: 10.1002/mdc3.12841. eCollection 2019 Nov. No abstract available.

PMID:
31745489
4.

GAD65-Ab encephalitis and subtle focal status epilepticus.

Goudot M, Frismand S, Hopes L, Verger A, Joubert B, Honnorat J, Tyvaert L.

Epileptic Disord. 2019 Oct 1;21(5):437-442. doi: 10.1684/epd.2019.1094.

PMID:
31649008
5.

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics.

Gréa H, Bouchet D, Rogemond V, Hamdani N, Le Guen E, Tamouza R, Darrau E, Passerieux C, Honnorat J, Leboyer M, Groc L.

Front Psychiatry. 2019 Sep 13;10:670. doi: 10.3389/fpsyt.2019.00670. eCollection 2019.

6.

Understanding auto-immune encephalitis in the ICU.

Sonneville R, Venkatesan A, Honnorat J.

Intensive Care Med. 2019 Dec;45(12):1795-1798. doi: 10.1007/s00134-019-05773-0. Epub 2019 Sep 25. No abstract available.

PMID:
31555853
7.

Epidemiology of paraneoplastic neurological syndromes: a population-based study.

Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, Valent F, Fabris M, Curcio F, Brigo F, Iacono D, Passadore P, Rana M, Honnorat J, Valente M.

J Neurol. 2020 Jan;267(1):26-35. doi: 10.1007/s00415-019-09544-1. Epub 2019 Sep 24.

PMID:
31552550
8.

Post-herpetic anti-N-methyl-d-aspartate receptor encephalitis in a pregnant woman.

Tailland M, Le Verger L, Honnorat J, Biquard F, Codron P, Cassereau J.

Rev Neurol (Paris). 2020 Jan - Feb;176(1-2):129-131. doi: 10.1016/j.neurol.2019.01.402. Epub 2019 Sep 18. No abstract available.

PMID:
31542179
9.

Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature.

Vogrig A, Bernardini A, Gigli GL, Corazza E, Marini A, Segatti S, Fabris M, Honnorat J, Valente M.

Cerebellum. 2019 Oct;18(5):976-982. doi: 10.1007/s12311-019-01075-9.

PMID:
31463826
10.

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.

Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto AL, Muñiz-Castrillo S, Roger M, Raimbourg J, Dayen C, Grignou L, Pallix-Guyot M, Lannoy J, Ducray F, Desestret V, Psimaras D, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 7;6(6). pii: e604. doi: 10.1212/NXI.0000000000000604. Print 2019 Nov.

11.

Fatal Anti-Ma2 Encephalitis Related to Treatment of Malignant Pleural Mesothelioma With a Combination of Anti-Programmed Death 1 and Anti-Cytotoxic T-Lymphocyte Associated Protein 4 Antibodies.

Du Rusquec P, Peyre A, Toulgoat F, Honnorat J, Raimbourg J.

J Thorac Oncol. 2019 Aug;14(8):e174-e176. doi: 10.1016/j.jtho.2019.03.017. No abstract available.

PMID:
31345342
12.

Seizure specificities in patients with antibody-mediated autoimmune encephalitis.

Vogrig A, Joubert B, André-Obadia N, Gigli GL, Rheims S, Honnorat J.

Epilepsia. 2019 Aug;60(8):1508-1525. doi: 10.1111/epi.16282. Epub 2019 Jul 8. Review.

PMID:
31283859
13.

Combined analysis of MGMT methylation and dynamic-susceptibility-contrast MRI for the distinction between early and pseudo-progression in glioblastoma patients.

Bani-Sadr A, Berner LP, Barritault M, Chamard L, Bidet CM, Eker OF, Hermier M, Guyotat J, Jouanneau E, Meyronet D, Gouttard S, D'Hombres A, Iziquierdo C, Honnorat J, Berthezène Y, Ducray F.

Rev Neurol (Paris). 2019 Oct;175(9):534-543. doi: 10.1016/j.neurol.2019.01.400. Epub 2019 Jun 14.

PMID:
31208813
14.

Unilateral clinical manifestations in LGI1-antibody encephalitis.

Gravier Dumonceau A, Jeannin-Mayer S, Roche P, Honnorat J, Joubert B, Thobois S, Laurencin C.

Rev Neurol (Paris). 2019 Sep - Oct;175(7-8):481-483. doi: 10.1016/j.neurol.2018.09.022. Epub 2019 Jun 8. No abstract available.

PMID:
31182313
15.

Impact of anti-CASPR2 autoantibodies from patients with autoimmune encephalitis on CASPR2/TAG-1 interaction and Kv1 expression.

Saint-Martin M, Pieters A, Déchelotte B, Malleval C, Pinatel D, Pascual O, Karagogeos D, Honnorat J, Pellier-Monnin V, Noraz N.

J Autoimmun. 2019 Sep;103:102284. doi: 10.1016/j.jaut.2019.05.012. Epub 2019 Jun 6.

PMID:
31176559
16.

Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis.

Chefdeville A, Treilleux I, Mayeur ME, Couillault C, Picard G, Bost C, Mokhtari K, Vasiljevic A, Meyronet D, Rogemond V, Psimaras D, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol Commun. 2019 Mar 11;7(1):38. doi: 10.1186/s40478-019-0693-7.

17.

Reversible myoclonus-ataxia encephalitis related to anti-mGLUR1 autoantibodies.

Gollion C, Dupouy J, Roberts M, Simonetta-Moreau M, Brefel Courbon C, Rascol O, Honnorat J, Magne FO.

Mov Disord. 2019 Mar;34(3):438-439. doi: 10.1002/mds.27634. Epub 2019 Feb 13. No abstract available.

PMID:
30759326
18.

Nonparaneoplastic autoimmune cerebellar ataxias.

Joubert B, Honnorat J.

Curr Opin Neurol. 2019 Jun;32(3):484-492. doi: 10.1097/WCO.0000000000000678. Review.

PMID:
30694927
19.

EEG analysis in anti-NMDA receptor encephalitis: Description of typical patterns.

Jeannin-Mayer S, André-Obadia N, Rosenberg S, Boutet C, Honnorat J, Antoine JC, Mazzola L.

Clin Neurophysiol. 2019 Feb;130(2):289-296. doi: 10.1016/j.clinph.2018.10.017. Epub 2018 Nov 29.

PMID:
30611120
20.

Balint syndrome in anti-NMDA receptor encephalitis.

Metzger A, Pisella L, Vighetto A, Joubert B, Honnorat J, Tilikete C, Desestret V.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 13;6(1):e532. doi: 10.1212/NXI.0000000000000532. eCollection 2019 Jan. No abstract available.

21.

Forecasting outcomes in anti-NMDAR encephalitis: Clearer prognostic markers needed.

Rüegg S, Yeh EA, Honnorat J.

Neurology. 2019 Jan 15;92(3):119-120. doi: 10.1212/WNL.0000000000006766. Epub 2018 Dec 21. No abstract available.

PMID:
30578369
22.

Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.

Vogrig A, Joubert B, Maureille A, Thomas L, Bernard E, Streichenberger N, Cotton F, Ducray F, Honnorat J.

J Neurol. 2019 Feb;266(2):398-410. doi: 10.1007/s00415-018-9143-x. Epub 2018 Nov 29.

PMID:
30498914
23.

Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis.

Maureille A, Fenouil T, Joubert B, Picard G, Rogemond V, Pinto AL, Thomas L, Ducray F, Quadrio I, Psimaras D, Berzero G, Antoine JC, Desestret V, Honnorat J.

J Neurol. 2019 Jan;266(1):195-206. doi: 10.1007/s00415-018-9132-0. Epub 2018 Nov 20.

PMID:
30460450
24.

Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations.

Izquierdo C, Barritault M, Poncet D, Cartalat S, Joubert B, Bruna J, Jouanneau E, Guyotat J, Vasiljevic A, Fenouil T, Berthezène Y, Honnorat J, Meyronet D, Ducray F.

Neurosurgery. 2019 Sep 1;85(3):E448-E456. doi: 10.1093/neuros/nyy513.

PMID:
30407589
25.

Opposing Morphogenetic Defects on Dendrites and Mossy Fibers of Dentate Granular Neurons in CRMP3-Deficient Mice.

Quach TT, Auvergnon N, Khanna R, Belin MF, Kolattukudy PE, Honnorat J, Duchemin AM.

Brain Sci. 2018 Nov 3;8(11). pii: E196. doi: 10.3390/brainsci8110196.

26.

TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.

Do LD, Gupton SL, Tanji K, Bastien J, Brugière S, Couté Y, Quadrio I, Rogemond V, Fabien N, Desestret V, Honnorat J.

Cerebellum. 2019 Apr;18(2):245-254. doi: 10.1007/s12311-018-0987-5.

27.

Structural mapping of hot spots within human CASPR2 discoidin domain for autoantibody recognition.

Liang W, Zhang J, Saint-Martin M, Xu F, Noraz N, Liu J, Honnorat J, Liu H.

J Autoimmun. 2019 Jan;96:168-177. doi: 10.1016/j.jaut.2018.09.012. Epub 2018 Oct 15.

PMID:
30337146
28.

Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.

Honnorat J, Joubert B.

Rev Neurol (Paris). 2018 Nov;174(9):597-607. doi: 10.1016/j.neurol.2018.07.006. Epub 2018 Sep 7. Review.

PMID:
30201423
29.

Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases.

Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J.

Eur J Neurosci. 2018 Aug;48(3):1906-1923. doi: 10.1111/ejn.14081. Epub 2018 Aug 16. Review.

PMID:
30028556
30.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J.

J Neurol. 2018 Oct;265(10):2190-2200. doi: 10.1007/s00415-018-8970-0. Epub 2018 Jul 12.

PMID:
30003358
31.

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.

Vialatte de Pémille C, Berzero G, Small M, Psimaras D, Giry M, Daniau M, Sanson M, Delattre JY, Honnorat J, Desestret V, Alentorn A.

Br J Cancer. 2018 Jul;119(1):105-113. doi: 10.1038/s41416-018-0125-7. Epub 2018 Jun 14.

32.

Immune-mediated ataxias.

Joubert B, Rostásy K, Honnorat J.

Handb Clin Neurol. 2018;155:313-332. doi: 10.1016/B978-0-444-64189-2.00021-4. Review.

PMID:
29891069
33.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR; T1D Exchange Biobank, Hampe CS.

Orphanet J Rare Dis. 2018 Apr 10;13(1):55. doi: 10.1186/s13023-018-0787-5.

34.

Autoimmune encephalitis and psychiatric disorders.

Honnorat J, Plazat LO.

Rev Neurol (Paris). 2018 Apr;174(4):228-236. doi: 10.1016/j.neurol.2017.11.004. Epub 2018 Mar 31. Review.

PMID:
29609960
35.

Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.

Jézéquel J, Lepleux M, Kahn RS, Honnorat J, Leboyer M, Groc L.

Am J Psychiatry. 2018 Apr 1;175(4):382-383. doi: 10.1176/appi.ajp.2017.17091053. No abstract available.

PMID:
29606071
36.

Nivolumab-induced myositis: A case report and a literature review.

Bourgeois-Vionnet J, Joubert B, Bernard E, Sia MA, Pante V, Fabien N, Honnorat J, Streichenberger N.

J Neurol Sci. 2018 Apr 15;387:51-53. doi: 10.1016/j.jns.2018.01.030. Epub 2018 Feb 3. Review. No abstract available.

PMID:
29571871
37.

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).

Reyes-Botero G, Cartalat-Carel S, Chinot OL, Barrie M, Taillandier L, Beauchesne P, Catry-Thomas I, Barrière J, Guillamo JS, Fabbro M, Frappaz D, Benouaich-Amiel A, Le Rhun E, Campello C, Tennevet I, Ghiringhelli F, Tanguy ML, Mokhtari K, Honnorat J, Delattre JY.

Oncologist. 2018 May;23(5):524-e44. doi: 10.1634/theoncologist.2017-0689. Epub 2018 Feb 22.

38.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R.

JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.

39.

Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.

Bronnimann C, Izquierdo C, Cartalat S, Thomas L, Joubert B, Delpech L, Barritault M, Meyronet D, Honnorat J, Ducray F.

J Neurooncol. 2018 May;138(1):141-145. doi: 10.1007/s11060-018-2780-1. Epub 2018 Jan 31.

PMID:
29388033
40.

Glioblastoma as differential diagnosis of autoimmune encephalitis.

Vogrig A, Joubert B, Ducray F, Thomas L, Izquierdo C, Decaestecker K, Martinaud O, Gerardin E, Grand S, Honnorat J.

J Neurol. 2018 Mar;265(3):669-677. doi: 10.1007/s00415-018-8767-1. Epub 2018 Jan 30.

PMID:
29383516
41.

Multiplex family with GAD65-Abs neurologic syndromes.

Belbezier A, Joubert B, Montero-Martin G, Fernandez-Vina M, Fabien N, Rogemond V, Mignot E, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 5;5(1):e416. doi: 10.1212/NXI.0000000000000416. eCollection 2018 Jan.

42.

Effect of thymectomy on refractory autoimmune status epilepticus.

Vogrig A, Pauletto G, Belgrado E, Pegolo E, Di Loreto C, Rogemond V, Honnorat J, Eleopra R.

J Neuroimmunol. 2018 Apr 15;317:90-94. doi: 10.1016/j.jneuroim.2018.01.009. Epub 2018 Jan 9.

PMID:
29336839
43.

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis.

Favier M, Joubert B, Picard G, Rogemond V, Thomas L, Rheims S, Bailhache M, Villega F, Pédespan JM, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J.

Eur J Paediatr Neurol. 2018 May;22(3):404-411. doi: 10.1016/j.ejpn.2017.12.014. Epub 2017 Dec 28.

PMID:
29310866
44.

Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies.

Hillary RP, Ollila HM, Lin L, Desestret V, Rogemond V, Picard G, Small M, Arnulf I, Dauvilliers Y, Honnorat J, Mignot E.

J Neuroimmunol. 2018 Feb 15;315:28-32. doi: 10.1016/j.jneuroim.2017.12.012. Epub 2017 Dec 18.

PMID:
29306402
45.

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, Attignon V, Wang Q, Rogemond V, Lay S, Ray-Coquard I, Pfisterer J, Joly F, Du Bois A, Psimaras D, Bendriss-Vermare N, Caux C, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.

PMID:
29299667
46.

Characteristics of cerebellar glioblastomas in adults.

Picart T, Barritault M, Berthillier J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E, Poncet D, Ducray F, Guyotat J.

J Neurooncol. 2018 Feb;136(3):555-563. doi: 10.1007/s11060-017-2682-7. Epub 2017 Dec 1.

PMID:
29196927
47.

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.

Jézéquel J, Johansson EM, Dupuis JP, Rogemond V, Gréa H, Kellermayer B, Hamdani N, Le Guen E, Rabu C, Lepleux M, Spatola M, Mathias E, Bouchet D, Ramsey AJ, Yolken RH, Tamouza R, Dalmau J, Honnorat J, Leboyer M, Groc L.

Nat Commun. 2017 Nov 27;8(1):1791. doi: 10.1038/s41467-017-01700-3.

48.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Izquierdo C, Alentorn A, Idbaih A, Simó M, Kaloshi G, Ricard D, Barritault M, Meyronet D, Bruna J, Honnorat J, Delattre JY, Ducray F.

J Neurooncol. 2018 Feb;136(3):533-539. doi: 10.1007/s11060-017-2677-4. Epub 2017 Nov 15.

PMID:
29143276
49.

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.

Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanché JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY, Psimaras D.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30. No abstract available.

50.

Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5.

Naudet N, Moutal A, Vu HN, Chounlamountri N, Watrin C, Cavagna S, Malleval C, Benetollo C, Bardel C, Dronne MA, Honnorat J, Meissirel C, Besançon R.

Cell Mol Life Sci. 2018 Jan;75(1):67-79. doi: 10.1007/s00018-017-2634-6. Epub 2017 Sep 1.

PMID:
28864883

Supplemental Content

Loading ...
Support Center